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a b s t r a c t
High mortality rates are associated with the life threatening
disease of sepsis. Improvements in septic patient survivability have
failed to materialize with currently available treatments. This
article represents data regarding a study published in biomaterials
(Vellaisamy et al., Biomaterials, 2015, in press). with the purpose of
evaluating whether severe sepsis mortality and associated hepatic
dysfunction induced by lipopolysaccharide (LPS) can be prevented
by cerium oxide nanoparticles (CeO2NPs) treatment in male
Sprague Dawley rats. Here we provide the information about the
method and processing of raw data related to our study publish in
Biomaterials and Data in Brief (Vellaisamy et al., Biomaterials,
2015, in press; Vellaisamy et al., Data in Brief, 2015, in press.). The
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/dib
Data in Brief
http://dx.doi.org/10.1016/j.dib.2015.04.022
2352-3409/& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
DOI of original article: http://dx.doi.org/10.1016/j.biomaterials.2015.04.025
n Correspondence to: Center for Diagnostic Nanosystems, Room 241N Robert C. Byrd Biotechnology Science Center, 1700 3rd
Ave. Marshall University, Huntington, WV 25755-1090, USA. Tel.: þ1 304 696 2708; fax: þ1 304 696 3766.
E-mail address: blough@marshall.edu (E.R. Blough).
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data contained in this article evaluates the contribution of MAPK
signaling in LPS induced sepsis. Macrophage cells (RAW 264.7)
were treated with a range of cerium oxide nanoparticle concen-
tration in the presence and absence of LPS. Immunoblotting was
performed on the cell lysates to evaluate the effect of cerium oxide
nanoparticle treatment on LPS induced changes in Mitogen
Activated Protein Kinases (MAPK) p-38, ERK 1/2, and SAPK/JNK
phosphorylation.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Specifications Table [please fill in right-hand column of the table below]
Subject area Biology
More specific subject area Nanomedicine
Type of data figure
How data was acquired Cell culture and immunoblotting
Data format Raw and analyzed
Experimental factors Raw 264.7 cells culture in the presence of LPS and CeO2 nanoparticles
Experimental features Balanced design that encompasses in vitro observations
Data source location Huntington, WV USA
Data accessibility The data presented in this article and is related to [1,2]
Value of the data
 The data can be referenced by other scientists investigating the effects of LPS on RAW 264.7 cells
MAPK signaling.
 The data can provide comprehensive analysis of the effect of cerium oxide nanoparticles on LPS-
induced MAPK signaling in cell culture
 These data provides a more thorough understanding of the MAPK involvement in LPS-induced
macrophage mediated signaling
1. Data, experimental design, materials and methods
1.1. Experimental design and methods
This articles contains data related to the research articles entitled “Inhibition of MAP kinase/NF-kB
mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide
nanoparticles in Biomaterials and Data in Brief article entitled “Cerium oxide nanoparticles inhibit
lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis” [1,2]. The purpose of this
study was to evaluate the contribution of Mitogen Activated Protein Kinase (MAPK) signaling in LPS
induced sepsis. For this study, macrophage cells (RAW 264.7) were grown and treated with different
concentration of cerium oxide nanoparticle in the presence and absence of LPS. Compared to that seen
in the control cells, LPS increased the phosphorylation of p-38, Phosphorylation of ERK 42/44 and
Phosphorylation of SAPK/JNK. CeO2 nanoparticle treatment significantly decreased LPS-induced
increases phosphorylation of p-38, Phosphorylation of ERK 42/44 and Phosphorylation of SAPK/JNK.
1.1.1. Macrophage culture and uptake of CeO2 NPs and protective effective of CeO2 NPs against LPS
To elucidate the contribution of MAPK signaling in LPS induced macrophage cells, RAW 264.7 cells
(ATCC) (1.2105/ml) were grown in 250 mm culture plate at 30 1C with 5% CO2 in DMEM high
glucose medium supplemented with 5% of fetal bovine, containing 1% Pen/Strep (10,000 U Penicillin
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and 10 mg Streptomycin/ml) and serum until 70–80% confluence and the media was replaced with the
fresh medium containing different doses of CeO2 NPs (0, 1, 5, 10, 25, 50, 100 and 1000 ng/ml) for 24 h
in the absence and presence of LPS.
1.1.2. Immunoblot analysis of LPS and LPSþCeO2 nanoparticles treated cells
Cells were washed with cold PBS, collected by scraping and centrifuged at 400 g for 10 min. Total
cell lysates was prepared by cell lyticTM M cell lysis reagent (Sigma) as outlined by the manufacturer.
Protein content was estimated in triplicate using the Bradford reagent with bovine serum albumin as
a standard. Western blot was performed as mentioned elsewhere. Fifty mg of total protein per well
was then subjected to electrophoresis and transfer to nitrocellulose Hybond-C membranes
(AmershamTM HybondTM) using standard conditions. Membranes were incubated overnight at
4 1C with the appropriate primary antibody for Phosho p-38, total p-38, Phospho ERK42/44, Phospho
SAPK JNK, Total SAPK JNK ( Cell Signaling, Dnavers, MA), washed extensively and then incubated for
1 h at room temperature with a HRP labeled anti-rabbit before detection by ECL (Western Blotting
Detection Reagent, GE Health Care Amersham, Piscataway, NJ). Immunoreactive signals were
quantified by densitometry using Alpha Innotech software (Santa Clara, California). Beta actin
immunoreactivity was used for normalization between samples.
Fig. 1. Effect of CeO2 nanoparticles on MAPK activation induced by LPS in RAW cells. Cells were exposed to LPS in the presence
and absence of CeO2 nanoparticles for 24 h. Expression of Phospho-p-38 ant total 38, Phospho ERK 42/44 and Phospho SAPK
JNK by western blot analysis.
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2. Results
Compared to that seen in the control cells, LPS increased the phosphorylation of p-38,
Phosphorylation of ERK 42/44 and Phosphorylation of SAPK/JNK. CeO2 nanoparticle treatment
significantly decreased LPS-induced increases phosphorylation of p-38, Phosphorylation of ERK 42/44
and Phosphorylation of SAPK/JNK (Fig. 1).
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